Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-23-000524
Filing Date
2023-07-18
Accepted
2023-07-18 17:16:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 apls13g.htm SC 13G 45552
  Complete submission text file 0000935836-23-000524.txt   46978
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90187 | Film No.: 231095030
SIC: 2834 Pharmaceutical Preparations

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G